The information provided herein is generated by experimental artificial intelligence and is for informational purposes only.
gsk reports strong year-end results and raises sales targets to 2031
GSK reported a strong fiscal year with a 7% increase in currency-adjusted revenue, reaching £31 billion, driven by growth in cancer treatments and innovative medicines. The company raised its sales targets to 2031 and announced a £2 billion share buyback over the next 18 months. Analysts have varied ratings for GSK, with Bernstein maintaining an 'Outperform' at a target of 2355 pence, while Deutsche Bank holds a 'Hold' rating with a target of 1450 pence.
Seems like the connection with the server has been lost. It can be due to poor or broken network. Please hang on while we're trying to reconnect...
Oh snap! Failed to reconnect with the server. This is typically caused by a longer network outage, or if the server has been taken down. You can try to reconnect, but if that does not work, you need to reload the page.
Oh man! The server rejected the attempt to reconnect. The only option now is to reload the page, but be prepared that it won't work, since this is typically caused by a failure on the server.